Categories: News

Pelitas Announces Appointment of Wyche T. Green (Tee) to its Board of Directors

PLANO, Texas, April 10, 2019 /PRNewswire/ — Pelitas (formerly DCS Global), the leader in Revenue Cycle Patient Access technology solutions, today announced that Tee Green, Chairman and CEO of 121G, LLC, has joined the Board of Directors. Mr. Green is an experienced software executive, investor, and board member and brings extensive healthcare industry depth of leadership and experience to the Pelitas board.

“The growing consumerism of healthcare and the increasing complexity in reimbursement create unique demands on providers in their efforts to increase cash while also creating loyalty in their patient population,” said Green. “Pelitas represents a unique opportunity for providers to do both, better.”   

Green started his career in banking operations upon graduation from Auburn University.  He was part of the founding team of Greenway Corporation where he led the sale of Greenway Corporation to the BISYS Group for $47.5 million.  Prior to the founding of 121G Mr. Green was the CEO of Greenway Medical Technologies. By way of organic growth and multiple acquisitions, Green led the company to the eventual merger of Greenway and two other companies which had over 2,000 employees and a $1.0 billion enterprise value. He continued as CEO of the combined companies until April of 2016.

“Tee is a visionary leader and an innovative healthcare technology pioneer who I have admired over my career,” said Steven Huddleston, CEO of Pelitas. “He is an exceptionally strong addition to our board as we sharpen our focus on innovation around the patient experience.”

Green has a wide array of public and nonpublic board service with current positions within healthcare and technology related companies including Pelitas, Caravan Health, ReferralPoint, WellBox, GreenCourt, Sonic Tools, Clearview Installations, Mint Health, and StreamLine Health, where he serves as Chairman of the Board.

“I am honored to serve on the Pelitas Board of Directors,” said Green. “The company has a strong history of delivering innovative solutions coupled and exceptional service to providers.”

About Pelitas
Pelitas provides industry-leading software and solutions to help healthcare providers increase patient loyalty, maximize revenue and reduce inefficiencies. The company’s innovative platform iPAS (Integrated Patient Access Solution) is designed to enhance reimbursement and collection early on by increasing the quality of patient registrations, maximizing point of service payments, and using cloud-based technology to facilitate electronic collaboration between the patient, provider, and payer.  With over 200 hospitals benefiting from its solutions, including large and small systems, academic medical centers, independents, and physician groups, Pelitas is uniquely positioned to increase cash and cultivate loyalty for all healthcare providers.  Learn more at www.pelitas.com

Contact for Inquiries
Peter Snell
214.810.6207
212510@email4pr.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/pelitas-announces-appointment-of-wyche-t-green-tee-to-its-board-of-directors-300828335.html

SOURCE Pelitas

Staff

Recent Posts

CBIH Welcomes Federal Momentum Toward Cannabis Rescheduling as 2026 Opens a New Window to Accelerate Medical Innovation and Growth, with CBIH Positioned to Capitalize on Emerging Opportunities

Houston, Texas--(Newsfile Corp. - December 22, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) (CBIH) announces…

29 minutes ago

XRP Healthcare® Secures Global Trademark Protection at the Intersection of Healthcare Services and XRP-Powered Payments

Multi-jurisdiction trademark coverage reinforces XRP Healthcare's position across digital health, pharmacy networks, and XRP-based payment…

1 hour ago

Black Book Poll: “Governed AI” Emerges as the Deciding Factor in 2026 NHS Procurement

Respondents report approvals and evaluation readiness are now the bottlenecks driving demand for reusable safety…

1 hour ago

Hemogenyx Pharmaceuticals PLC Announces Update on Admission of Shares

LONDON, UK / ACCESS Newswire / December 22, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the…

1 hour ago

What Is the Best GLP-1 Supplement for Weight Loss? Industry Analysis Reveals Probiotic Akkermansia Formulas as Affordable Ozempic Alternatives

Health Journey Addresses 'Best GLP-1 Supplement' Question with Akkermansia-Based Formula Analysis as Six-Month Costs Compare…

22 hours ago